Felipe Bernardes

Felipe Bernardes

Auto-generated profile, based on publicly available information

Felipe Bernardes

Androscience, Science and Innovation Center in Andrology and High‐Complex Clinical and Research Andrology Laboratory Sao Paulo Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Andrology
Verified
Journal Article
Open access
PDF file
JHJorge Hallak
Jorge Hallak
Thiago A. TeixeiraThiago A. Teixeira
Thiago A. Teixeira
FBFelipe S. Bernardes
Felipe S. Bernardes
FCFelipe Carneiro
Felipe Carneiro
SDSergio A. S. Duarte
Sergio A. S. Duarte
Paulo SaldivaPaulo Saldiva
Paulo Saldiva
Background: The current outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, named coronavirus disease 19 (COVID‐19), is not the first well‐known spillover of an animal originated virus to infect humans. However, one of the few to make such a fast jump in a powerful evolutionary shortcut. The incredible pattern of aggressiveness worldwide since the beginning of the outbreak is that up to 20% of those infected need hospitalization and 5% evolve to critical conditions, not limited to respiratory‐related issues, but rather to systemic involvement.Objective: This study aims to summarize the current knowledge about the effects of SARS‐CoV‐2 infection on the male genitourinary tract.Materials and methods: A narrative review was carried out to identify articles on the SARS‐CoV‐2 infection on the male genitourinary system.Results: Considerations were made about the molecular characteristics of SARS‐CoV‐2 and immune response to coronavirus. We discussed the influence of the virus on the urinary system, potential mechanisms of COVID‐19‐ related acute kidney injury (AKI), and the role of cytokine release syndrome on the renal pathophysiology of the disease. In the male reproductive tract, it was discussed the testis' vulnerability to SARS‐CoV‐2 invasion and the possible adverse effects on its function and the seminal findings of COVID‐19.Discussion and conclusion: During the COVID‐19 pandemic, an international coordinated scientific effort must arise to understand the role of the urogenital system in the SARS‐CoV‐2 infection in the clinical setting.

9 February 2021 in Andrologia
Verified
Journal Article
Closed access
PDF file
FCFelipe Carneiro
Felipe Carneiro
Thiago A. TeixeiraThiago A. Teixeira
Thiago A. Teixeira
FBFelipe S. Bernardes
Felipe S. Bernardes
MPMarcelo S. Pereira
Marcelo S. Pereira
GMGiovanna Milani
Giovanna Milani
JHJorge Hallak
Jorge Hallak

1 June 2013 in International braz j urol
Verified
Journal Article
Open access
PDF file
JPJose Pontes-Junior
Jose Pontes-Junior
SRSabrina Thalita Reis
Sabrina Thalita Reis
FBFelipe S. Bernardes
Felipe S. Bernardes
LOLuiz C. N. Oliveira
Luiz C. N. Oliveira
EBErika Aparecida Felix de Barros
Erika Aparecida Felix de Barros
KLKatia Ramos Moreira Leite
Katia Ramos Moreira Leite
Integrins are transmembrane glycoprotein receptors that regulate cell-matrix interactions, thus functioning as sensors from the environment. They also act as cell adhesion molecules that are responsible for the maintenance of the normal epithelial phenotype. Some studies have reported a correlation between carcinogenesis and changes in integrin expression, especially β1 integrin, however its role in prostate cancer (PC) is unclear. The aim of our study was to evaluate the expression of β1 integrin in localized PC and to correlate the pattern of expression with recurrence after surgical treatment. Methods For this case-control study, we retrospectively selected surgical specimens from 111 patients with localized PC who underwent radical prostatectomy. Recurrence was defined as a PSA level exceeding 0.2ng/mL after surgery, and the median follow-up was 123 months. Integrin expression was evaluated by immunohistochemistry in a tissue microarray containing two samples from each tumor. We employed a semiquantitative analysis and considered a case as positive when the expression was strong and diffusely present.

1 April 2020 in Journal of Urology
Verified
Journal Article
Closed access
FBFelipe Bernardes
Felipe Bernardes
MSMatheus Siqueira
Matheus Siqueira
GEGustavo Ebaid
Gustavo Ebaid
GMGustavo Messi
Gustavo Messi
RFRenato Falci
Renato Falci
APAffonso Piovesan
Affonso Piovesan
INTRODUCTION AND OBJECTIVE: Kidney disease (CKD) are known to increase the risk of venous thromboembolism. Also, the prevalence of atrial fibrillation (AF) is at least 10-fold higher than in the general population. Warfarin is the most common oral anticoagulant drug used to prophylactic therapy (OAT) in these patients. When CKD patients enter a Kidney transplant (KT) waiting list, they often remain on OAT. This implies the use of reversal agents at the time of Kidney transplant surgery specially with deceased donors. In this study, we aim to determine the outcomes and complications of KT in patients using OAT at the time of surgery. METHODS: From January 2009 to September 2019 2403 kidney transplants were done in our institution. There were 15 patients with current OAT use at the time of the procedure. We reviewed each patient record to determine OAT indication, type of anticoagulant in use, INR based on prothrombin time (PT) test prior to surgery, reversal drugs employed, concomitant use of Antiplatelets drugs, and need to reintroduction of OAT after KT. Surgical complications as well as long term graft function (estimated by MDRD and creatinine) were also investigated. RESULTS: From the 15 patients, 8 were male (53,3%) and 13 (86,7%) received kidney from deceased donors. Mean age was 54,6±11,0 years. Risk factors for thrombosis were the indication for ACO in 9 (60%) including arteriovenous fistula or hemodialysis catheter thrombosis and previous graft loss due to thrombotic event. In the remaining 6 (40%) OAT indication was AF. Eight patients (53,3%) were in concomitant use of Antiplatelets. Median INR in admission test was 2,2±1,0. On 12 patients (80%) the reversion therapy was vitamin K and fresh frozen plasma. The remaining 3 (20%) had INR < 1,5, dismissing treatment. Surgical excessive bleeding requiring transfusion were observed in 7 (46,7%) patients, and there were 02 deaths related to these complications. Re-introduction of OAT was necessary in 8 (53,3%) individuals. There was no statistical difference between long term renal graft function, with a median MDRD of 57,55 and creatinine of 1,6 after 5 years. CONCLUSIONS: Oral anticoagulants use adds surgical risks for bleeding complications and death in kidney transplant recipients, independently of anticoagulant reversal therapy. Source of Funding: None

1 April 2020 in Journal of Urology
Verified
Journal Article
Closed access
MSMatheus Siqueira
Matheus Siqueira
FBFelipe Bernardes
Felipe Bernardes
HKHideki Kanashiro
Hideki Kanashiro
IAIoannis Antonopoulos
Ioannis Antonopoulos
ABAlexandre Bull
Alexandre Bull
APAffonso Piovesan
Affonso Piovesan

1 April 2020 in Journal of Urology
Verified
Journal Article
Closed access
APAffonso Piovesan
Affonso Piovesan
RSRogério Sayâo
Rogério Sayâo
MSMatheus Siqueira
Matheus Siqueira
FBFelipe Bernardes
Felipe Bernardes
WNWillian Nahas
Willian Nahas